Subscribe
shutterstock_1214634313_piotr_swat
Piotr Swat / Shutterstock.com
24 March 2020GenericsRory O'Neill

Israel imports patented antivirals for treating COVID-19

Israel has approved generic versions of an HIV antiviral owned by  AbbVie for use in treating coronavirus, despite the company still holding patent protection and doubts over its effectiveness.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Costa Rica asks WHO to create voluntary COVID-19 IP pool
26 March 2020   The Costa Rican government has asked the World Health Organization to create a voluntary pool to collect patent rights for technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.
Big Pharma
EU should buy patent rights for COVID-19 tests, says Greece
7 April 2020   Greece has reportedly suggested that EU member states should jointly buy patent rights for COVID-19 tests and vaccines to ensure rapid distribution across the EU.
Big Pharma
Israel targets Teva over MS drug royalties
12 May 2022   The state of Israel has sued Teva Pharmaceuticals for $100 million over alleged unpaid royalties relating to its multiple sclerosis drug, Copaxone.


Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

Editor's picks

Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Americas
Litigation implications of the USPTO’s terminal disclaimer proposal
29 August 2024
Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Europe
Labour govt appoints new Minister with IP oversight
9 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024

More on this story

Americas
Costa Rica asks WHO to create voluntary COVID-19 IP pool
26 March 2020   The Costa Rican government has asked the World Health Organization to create a voluntary pool to collect patent rights for technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.
Big Pharma
EU should buy patent rights for COVID-19 tests, says Greece
7 April 2020   Greece has reportedly suggested that EU member states should jointly buy patent rights for COVID-19 tests and vaccines to ensure rapid distribution across the EU.
Big Pharma
Israel targets Teva over MS drug royalties
12 May 2022   The state of Israel has sued Teva Pharmaceuticals for $100 million over alleged unpaid royalties relating to its multiple sclerosis drug, Copaxone.

More on this story

Americas
Costa Rica asks WHO to create voluntary COVID-19 IP pool
26 March 2020   The Costa Rican government has asked the World Health Organization to create a voluntary pool to collect patent rights for technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.
Big Pharma
EU should buy patent rights for COVID-19 tests, says Greece
7 April 2020   Greece has reportedly suggested that EU member states should jointly buy patent rights for COVID-19 tests and vaccines to ensure rapid distribution across the EU.
Big Pharma
Israel targets Teva over MS drug royalties
12 May 2022   The state of Israel has sued Teva Pharmaceuticals for $100 million over alleged unpaid royalties relating to its multiple sclerosis drug, Copaxone.

More features

Gilead scores win in fake HIV drug dispute
Polsinelli grows roster with ex-corporate counsel
‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird
Sandoz wins $137.2m payout for lost profits in generic launch
Sanofi signs global rights deal to develop rare cancer therapy
Unified Patent Court visualised: Cases, divisions, and classes in charts
WBD to merge with firm to create ‘powerhouse’ practice
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers